KALA
NASDAQ
$0.75
Kala Bio Inc (KALA)
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development and commercialization of therapies using its proprietary nanoparticle-based mucus penetrating particle (MPP) technology for the treatment of eye diseases. The company is headquartered in Watertown, Massachusetts.
Sector:
Healthcare
Industry:
Biotechnology
Target: $1.50 (+100.03%)
Market Cap
$19M
Price Chart
Valuation
Market Cap$19M
P/S23.75
P/B1.67
Profitability
Gross Profit (TTM)$1.33M
EBITDA-$30M
EPS-$4.16
Growth & Risk
EPS 5Y CAGR-46.66%
FCF 5Y CAGR-24.06%
Sharpe Ratio-2.22